Male factor infertility with characterized by Teratozoospermia. Male Infertility
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male participants are characterized by fresh ejaculated spermatozoa with a concentration of at least 5 million/ml , Teratozospermia and having indication for ICSI because of male infertility. female partners aged under 38 years old, without poor ovarian response and having day 3 serum FSH < 15 IU/lit will be entered the study
Exclusion criteria
Exclusion criteria: Testicular samples and ejaculate samples with concentration below 5 million / ml ?female partner with poor ovarian response, endometriosis, and cases with no embryo to transfer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Embryo development. Timepoint: 3 days after microinjection. Method of measurement: Based on Hill's grading.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Evaluation of B HCG in blood serum.;Clinical Pregnancy. Timepoint: 8 weeks after embryo transfer. Method of measurement: detection of embryo heart beat in abdominal sonography.;Fertilization Rate. Timepoint: 16-18 hours after microinjection. Method of measurement: evaluation the formation of 2 pronucleous under the microscope.;Embryo implantation rate. Timepoint: 6weeks after embryo transfer. Method of measurement: detection the number of gestational sac in abdominal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation SDF and STL in sperms with scores between 0-6. Timepoint: Before randomization. Method of measurement: Sperm DNA fragmentation test, Sperm Telomere Assay. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yazd University of Medical Sciences